The Patent Finder
US

Benzolactam Compounds as Protein Kinase Inhibitors

US 11,939,321 In force, term unresolved
OverviewFamilyAssignmentsSources & methods

Also listed on Sygnature Discovery Limited, an earlier holder on the record. The recorded assignments below show how it moved.

Term ends no later than Oct 20, 2036 · Low confidence

In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.

Filed Apr 7, 2021 as application 17/224,733 · Granted Mar 26, 2024
Base term, 20 years from filing
Today
20 years from filing
2016 2036
Clock starts
Oct 20, 2016
Ends no later than
Oct 20, 2036
Granted
Mar 26, 2024
base term Updated Nov 19, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
Unresolved
Terminal disclaimer
On file, reference document not resolved, so the date above is an upper bound. We do not guess the cap.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
5
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. 0 of 3 maintenance fees are paid so far. Confidence: Low. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Oct 20, 2016, when application PCT/IB2016/001507, the earliest non-provisional in its chain, was filed (this one was filed Apr 7, 2021); a parent in its chain could not be resolved (the next row)Oct 20, 2036High confidence
Continuity chainA parent in the chain could not be resolveddated from this application's own claimMedium confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer on file (approved), reference document not resolvedno cap applied, and none guessedMedium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events0 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderno later than Oct 20, 2036Low confidence

Partial family

Application PCT/IB2016/001507PCT application
no patent term
no patent term
US 10,457,669In force
Oct 2036
Oct 2036
US 11,001,575In force
Oct 2036
Oct 2036
US 11,939,321this patent
no later than Oct 2036
no later than Oct 2036
US 12,655,137In force
Nov 2037
Nov 2037
Partial: 1 of the 5 has no file history here, so its row comes from the patent's own record or names the application alone. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Apr 7, 2021
Reel 55856, frame 25
Astex Therapeutics LimitedOtsuka Pharmaceutical Co., Ltd.Assignment of Assignor's Interest
Apr 7, 2021
Reel 55856, frame 68
Cooke, Michael Liam; Cousin, David; Onions, Stuart Thomas; Shannon, Jonathan Martin; Watts, John PaulSygnature Discovery LimitedAssignment of Assignor's Interest
Apr 8, 2021
Reel 55861, frame 79
Berdini, Valerio; Buck, Ildiko Maria; Day, James Edward Harvey; Griffiths-jones, Charlotte Mary; Heightman, Thomas Daniel; Howard, Steven; Murray, Christopher William; Norton, David; O'reilly, Marc; Woolford, Alison Jo-anneAstex Therapeutics LimitedAssignment of Assignor's Interest
Apr 8, 2021
Reel 55861, frame 86
Sygnature Discovery LimitedAstex Therapeutics LimitedAssignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited